AMA, AHA Call For Drug Pricing Transparency, Increased Competition
Inside Health Policy
Representatives from the American Medical Association and the American Hospital Association called for increased drug pricing transparency and reduced regulations to increase competition at a panel on Monday (Sept. 25) on the cost of drugs at America’s Health Insurance Plans’ Medicare conference…Read More.
Want to Bring Down Drug Prices? Go After the Middleman
The American Prospect
“Pharmacy benefit managers”—companies that claim to lower prices—actually jack them up…Read More.
Hospital Impact—PBMs are worsening the opioid epidemic
For Americans younger than 50, the leading cause of death used to be injuries caused by accidents. Now, the biggest killer isn’t car crashes or ladder falls—it’s drug overdoses…Read More.
Middlemen Who Save $$ On Medicines — But Maybe Not For You
Kaiser Health News
Pharmacy benefit managers — companies that are often unnoticed and even less understood by most consumers — hold an important place in the prescription drug-pricing pipeline…Read More.
Market Reforms To Improve Pharmaceutical Outcomes
The drama of “repeal and replace” resembled an unfunny version of a Monty Python skit, continuously claiming that it was “not dead yet”, and even that it was “getting better” only to be put out of its misery in the end…Read More.
Price Transparency Is Critical to Drug Pricing Solutions
Prescription drug costs are a hot political issue, not as much because of the share of the U.S. health care dollar they consume but because consumers pay a larger share of their drug costs out of pocket than they do for other health care…Read More.
Pharmacy `Clawbacks’ Focus of Newest State Law on PBMs
A new law in Connecticut would close a drug price loophole that’s been the subject of more than a dozen lawsuits around the U.S., taking aim at a practice by pharmacy benefit managers called pharmacy clawbacks…Read More.
Unaccountable Benefit Managers: How PBMs Put Profits Over Patients
A young husband was diagnosed with advanced melanoma and tumors attached to his brain. Waiting on the other side of his oncology clinic’s pharmacy counter was a potentially life-prolonging drug…Read More.